Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (41-50 of 1,137) with videos related to

Pageof 114
Sort By:
Journal of the American College of Cardiology|March 20, 2003
Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trialChristopher P Cannon
Circulation|September 25, 2002
Evidence-based risk stratification to target therapies in acute coronary syndromesChristopher P Cannon
Clinical Cardiology|August 16, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--Part IChristopher P Cannon
Controlled Clinical Trials|December 31, 1997
Clinical perspectives on the use of composite endpointsC P Cannon
Reviews in Cardiovascular Medicine|October 18, 2003
Critical pathways for acute myocardial infarctionChristopher P Cannon
European Heart Journal|March 24, 2022
Statin intolerance: how common is it and how do we work with patients to overcome it?Christopher P Cannon
Clinical Cardiology|September 24, 1999
Breaking the therapeutic barriers: new strategies for acute coronary syndromesC P Cannon
Clinical Cardiology|September 24, 1999
Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarctionC P Cannon
Contemporary Internal Medicine|April 8, 1995
Improved management of unstable angina and non-Q-wave MIC P Cannon
Contemporary Internal Medicine|July 7, 1994
Advances in the treatment of acute MIC P Cannon
Pageof 114

Showing results (41-50 of 1,137) with videos related to

Sort By:
Pageof 114
Journal of the American College of Cardiology|March 20, 2003
Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trialChristopher P Cannon
Circulation|September 25, 2002
Evidence-based risk stratification to target therapies in acute coronary syndromesChristopher P Cannon
Clinical Cardiology|August 16, 2003
Oral platelet glycoprotein IIb/IIIa receptor inhibitors--Part IChristopher P Cannon
Controlled Clinical Trials|December 31, 1997
Clinical perspectives on the use of composite endpointsC P Cannon
Reviews in Cardiovascular Medicine|October 18, 2003
Critical pathways for acute myocardial infarctionChristopher P Cannon
European Heart Journal|March 24, 2022
Statin intolerance: how common is it and how do we work with patients to overcome it?Christopher P Cannon
Clinical Cardiology|September 24, 1999
Breaking the therapeutic barriers: new strategies for acute coronary syndromesC P Cannon
Clinical Cardiology|September 24, 1999
Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarctionC P Cannon
Contemporary Internal Medicine|April 8, 1995
Improved management of unstable angina and non-Q-wave MIC P Cannon
Contemporary Internal Medicine|July 7, 1994
Advances in the treatment of acute MIC P Cannon
Pageof 114